IMV Inc IMVIQ

Publication of SPiReL data and class action

[Breakthorough1]

SPiReL data have just been published in a journal. In the population CD20+/PDL-1+, 56% of the total of patients, it gives:

 

 

ORR: 46% 

 

DCR: 77% 

 

mPFS: 7'1 months (Lonca -accelerated approval in April 2021- gave 4'9 months).

 

mOS: 17'4 months (Lonca gave 9'5 months).

 

In the ITT ("Intention to Treat") population, it gave 10'1 months (still better than Lonca).

 

They insist in the possibility of combination, given the low toxicity.

https://onlinelibrary.wiley.com/doi/10.1111/ejh.13982

Does anyone knows about class action being organized in relation to the misleading statements?

[Sandinista]

Of course it works. Rumor is IMV is being sold for 3-5 million, it's probably worth 300-500 million, or more. And on top of that, creditors get compensated in the sale, followed by IMV employees, you know, the people who ruined the company. Retail shareholders get shite all.  Thanks Andy and board. Truly remarkable talent and Great leadership.   

[Breakthorough1]

Is this is the rumor, we should collect all the misleading statements and initiate a class action. They are any: - Announcements related to COVID Vaccine resukts which never came. - Announcements related to VITALIZE results giving a date always delayed. - Announcements about financind, like that of Andrew Hall in an interview with Thom Calandra in January 2022, where it was stated that Merck